Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain
- 15 April 2008
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 36 (2) , 117-125
- https://doi.org/10.1016/j.jpainsymman.2007.09.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic reviewBritish Journal of Cancer, 2006
- The association between negative affect and opioid analgesia in patients with discogenic low back painPain, 2005
- Buprenorphine: Considerations for Pain ManagementJournal of Pain and Symptom Management, 2005
- Opioids in renal failure and dialysis patientsJournal of Pain and Symptom Management, 2004
- Opioids and renal functionThe Journal of Pain, 2004
- Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trialClinical Therapeutics, 2003
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePAIN®, 2001
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Severe undertreatment of cancer pain: A 3-year survey of the German situationJournal of Pain and Symptom Management, 1995
- Special study designs: early escape, enrichment, studies in non-respondersCommunications in Statistics - Theory and Methods, 1994